| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |